SCHEMBL28054733

SCHEMBL28054733

CC(C)(C)OC1CC(NC=O)N(C(=O)C(C)(C)C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27879617 0.81 NR1H2 (0.30) —
SCHEMBL27896387 0.80 TSHR (0.40) —
SCHEMBL28054871 0.78 PIK3CD (0.39) —
SCHEMBL27896399 0.75 TSHR (0.42) —
SCHEMBL27420086 0.74 RIPK1 (0.30) —
SCHEMBL27896395 0.74 LMNA (0.41) —
SCHEMBL27896421 0.72 KMT2A (0.42) —
SCHEMBL27879651 0.71 — —
SCHEMBL27896447 0.69 — —
SCHEMBL14155394 0.67 MMP2 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102791693-B Hepatitis c virus inhibitors BRISTOL-MYERS SQUIBB CO. (US) 2016-04-13 — — CN claimed
Send feedback